Morgan Stanley’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-10
| Closed | -$185 | – | 7935 |
|
|
2023
Q3 | $185 | Sell |
10
-178
| -95% | -$3.29K | ﹤0.01% | 7391 |
|
|
2023
Q2 | $5.34K | Sell |
188
-96
| -34% | -$2.73K | ﹤0.01% | 6973 |
|
|
2023
Q1 | $15.8K | Buy |
284
+193
| +212% | +$10.8K | ﹤0.01% | 6714 |
|
|
2022
Q4 | $1.97K | Sell |
91
-285
| -76% | -$6.17K | ﹤0.01% | 7379 |
|
|
2022
Q3 | $11K | Sell |
376
-1,259
| -77% | -$36.8K | ﹤0.01% | 7049 |
|
|
2022
Q2 | $52K | Buy |
1,635
+927
| +131% | +$29.5K | ﹤0.01% | 6595 |
|
|
2022
Q1 | $68K | Sell |
708
-41
| -5% | -$3.94K | ﹤0.01% | 6546 |
|
|
2021
Q4 | $146K | Buy |
749
+281
| +60% | +$54.8K | ﹤0.01% | 6230 |
|
|
2021
Q3 | $94K | Buy |
468
+417
| +818% | +$83.8K | ﹤0.01% | 6418 |
|
|
2021
Q2 | $20K | Buy |
+51
| New | +$20K | ﹤0.01% | 7014 |
|